期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Planning Target Volume Margin in Linac-Based Stereotactic Radiosurgery for Brain Metastases
1
作者 Hany S. Attallah Radwa M. Hamed +5 位作者 Khaled M. EL-Shahat Aliaa Mahmoud Mahmoud Abdallah ibraheem haggag Emad Moustafa Adel Yassin 《Journal of Cancer Therapy》 2024年第7期265-272,共8页
Background: The treatment of brain metastases with radiotherapy has shifted to the use of Stereotactic Radio-surgery (SRS). The technical issue of expanding the treatment volume around the Gross Tumor Volume (GTV) is ... Background: The treatment of brain metastases with radiotherapy has shifted to the use of Stereotactic Radio-surgery (SRS). The technical issue of expanding the treatment volume around the Gross Tumor Volume (GTV) is a current debate. Radiotherapy centers use variable GTV-PTV margins, ranging from one to 2 mm. Material and Methods: We performed a dosimetric comparison in plans of twenty patients using three margins: PTV zero, PTV1, and PTV2. We also developed imaginary Peel volumes. These volumes are described as follows: Peel1 = PTV1 − GTV, Peel2 = PTV2 − GTV. Results: Our results showed that the mean PTV volume differed significantly across the different margins (p = 0.000). The V12 of the brain significantly varied as a function of PTV margin (p = 0.000). The target coverage and plan quality indices were not significantly different. The Peel volume dosimetric analysis showed that the mean dose was significantly higher in the nearby normal brain tissue: Peel1 (p = 0.022) and Peel 2 (p = 0.013). Conclusion: According to our dosimetric analysis, expanding the GTV into a PTV by 1 mm margin is more convenient than 2 mm. 展开更多
关键词 SRS Brain Metastases PTV
下载PDF
Radiotherapy to the Left Breast with 3DCRT, IMRT or VMAT: International Medical Center Experience
2
作者 Hany S. Attallah Radwa M. Hamed +5 位作者 Haytham A. Abdelkader Mahmoud M. Abdallah Aliaa Mahmoud ibraheem haggag Bassam E. Makram Ahmed M. El-Saeed 《Journal of Cancer Therapy》 2021年第3期107-115,共9页
Radiation therapy after conservative breast surgery is an integral part of the treatment of early breast cancer</span><span style="font-family:Verdana;">.</span></span></span>&l... Radiation therapy after conservative breast surgery is an integral part of the treatment of early breast cancer</span><span style="font-family:Verdana;">.</span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The aim of radiotherapy is</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> to achieve the best coverage of </span><span style="font-family:Verdana;">the</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Planning</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> Target Volume (PTV</span><span style="font-family:Verdana;">),</span><span style="font-family:Verdana;"> while reducing the dose to the Organs at Risk (OAR). Such goals are not always achievable with the conformal three dimensions plans (3DCRT). Recently, </span><span style="font-family:Verdana;">radiation</span><span style="font-family:Verdana;"> oncologist uses Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT)</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">for irradiating the breast. In this study, we compared 3DCRT, IMRT </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> VMAT for left breast cancer patients in terms of PTV coverage, OAR</span><span style="font-family:Verdana;">.</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">We</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> also revised the different dose distribution in 1) different breast volume categories, 2) nodal irradiation versus breast only, and 3) boost versus no boost. Results</span><span style="font-family:Verdana;">:</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> routinely reported dose </span><span style="font-family:Verdana;">constrains</span><span style="font-family:Verdana;"> for the ipsilateral lung and </span><span style="font-family:Verdana;">for</span><span style="font-family:Verdana;"> the heart were not significantly different on comparing the three techniques. While for the contralateral lung, the difference in mean dose was in favor of 3DCRT.</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">In large breast </span><span style="font-family:Verdana;">volume,</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">3DCRT provided a lower Max dose to the contralateral </span><span style="font-family:Verdana;">lung</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">and</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> the</span></span></span><span><span><span style="font-family:""> <span style="font-family:Verdana;">lowest</span><span style="font-family:Verdana;"> mean dose to the contralateral breast when compared to IMRT p < 0. 046</span><span style="font-family:Verdana;">.</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">In</span></span></span><span><span><span style="font-family:""> <span style="font-family:Verdana;">case</span><span style="font-family:Verdana;"> of no nodal irradiation, the contralateral breast </span><span style="font-family:Verdana;">mean</span><span style="font-family:Verdana;"> dose was lower in 3DCRT in comparison to IMRT and VMAT p < 0.037. When boost dose was given, 3DCRT plans had produced a lower Max dose to the contralateral lung p < 0.017. Conclusion</span><span style="font-family:Verdana;">:</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> three techniques (3DCRT, IMRT, and VMAT) can meet the clinical dosimetry demands of radiotherapy for left breast cancer after conservative surgery, as long as the routinely OARs only (heart and ipsilateral lung) </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">are</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> reported. Our study showed that 3CDRT can provide a lower dose to the contralateral organs (breast and lung), </span><span style="font-family:Verdana;">specially</span><span style="font-family:Verdana;">, in case of large breast volumes, no nodal irradiation </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> when a boost </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">is </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">given</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">. 展开更多
关键词 Left Breast Radiotherapy 3DCRT IMRT VMAT Large Breast Nodal Irradiation Boost
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部